Tongfang Kontafarma Holdings Limited Price (1312.HK)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

5,578,713,777

(0)%

Tongfang Performance History

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

Tongfang Kontafarma Holdings Limited, an investment holding company, engages in the manufacture and sale of prescription drugs and laboratory related products in Mainland China, Singapore, Taiwan, and the United States. The company operates in Pharmaceutical Business and Fitness Business segments. It also offers chemical drugs and prescribed traditional Chinese medicines; operates fitness centers; operates in the franchise business; and provides consultation services for fitness and health activities. The company trades in laboratory related products; re... Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $0.024-0.048
  • Market Cap 150.63M
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Drug Manufacturers - Specialty & Generic

  • ceo: Mr. Feifei Wang
  • IPO Date: January, 18, 2012
  • Country: HK
  • Currency: HKD
  • Headquaters: No Data
  • Employees: 717

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation